Airflow optimization reduces time required to remove particulate matter from the classroom

According to the WHO, about 7 million people die each year due to air pollution. Particulate matter (PM) triggers inflammatory responses in the human body, causing asthma and other respiratory and cardiovascular diseases. It is more fatal for young and growing students. The Korea Institute of Civil Engineering and Building Technology (KICT) has reduced time required to remove particulate matter […]

Read more

No Link Between Childhood Vaccinations and Allergies or Asthma

A meta-analysis by Australian researchers found no link between childhood vaccinations and an increase in allergies and asthma. In fact, children who received the BCG vaccine actually had a lesser incidence of eczema than other children, but there was no difference in shown in any of the allergies or asthma. The researchers, in a report published in the journal Allergy, […]

Read more

Nighttime Asthma Predicts Poor Outcomes in Teens

Teens with persistent nocturnal asthma symptoms were significantly more likely than were those without nighttime asthma to report poor functional health independent of daytime asthma, based on data from 430 adolescents aged 12-16 years. Approximately half of children with severe asthma experience at least one night of inadequate sleep per week, and lost sleep among young children with asthma has […]

Read more

Release of serotonin from mast cells contribute to airway hyperresposivness in asthma

In asthma, the airways become hyperresponsive. Researchers from Uppsala University have found a new mechanism that contributes to, and explains, airway hyperresponsiveness. The results are published in the scientific journal Allergy. Some 10 percent of Sweden’s population suffer from asthma. In asthmatics, the airways are hyperresponsive (overreactive) to various types of stimuli, such as cold air, physical exertion and chemicals. […]

Read more

Terry White Chemists Meloxicam

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TERRY WHITE CHEMISTS MELOXICAM TABLETS Contains the active ingredient, meloxicam Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking your medicine This leaflet answers some common questions about meloxicam. It does not contain all the available information. It does not take the […]

Read more

APO-Frusemide

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-FRUSEMIDE TABLETS Contains the active ingredient furosemide (frusemide) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All […]

Read more

Reyataz

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. REYATAZ® (Ray-uh-taz) Atazanavir (Ata-zan-a-vir) Consumer Medicine Information What is in this leaflet Read this leaflet carefully before taking REYATAZ. This leaflet answers some common questions about REYATAZ. It does not contain all the available information. It does not take the place of talking to your doctor or […]

Read more

Clopidogrel Winthrop Plus Aspirin

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CLOPIDOGREL WINTHROP PLUS ASPIRIN® Clopidogrel (clop-id-o(h)-grel) and Aspirin (as-per-in) Consumer medicine information What is in this leaflet This leaflet answers some common questions about Clopidogrel Winthrop Plus Aspirin tablets. It does not contain all the available information. Some of the information it contains may not apply to […]

Read more

Breo Ellipta

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BREO ELLIPTA Fluticasone furoate 100 or 200 micrograms and vilanterol (as trifenatate) 25 micrograms per inhalation Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you start using BREO ELLIPTA. This leaflet answers some common questions about BREO ELLIPTA. It does not […]

Read more

Pentasa Enema

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. PENTASA® (MESALAZINE) ENEMA Enema mesalazine Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about PENTASA. It does not contain all the available information.It does not take the place of talking to your doctor or pharmacist. Please read this leaflet before you […]

Read more
1 2 3 4